These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 557157)

  • 1. The effect of D-lysergic acid diethylamide (LSD) upon shock elicited fighting in rats.
    Sheard MH; Astrachan DI; Davis M
    Life Sci; 1977 Feb; 20(3):427-30. PubMed ID: 557157
    [No Abstract]   [Full Text] [Related]  

  • 2. Tricyclic antidepressant drugs: antagonism of effect of D-lysergic acid diethylamide (LSD) on shock elicited aggression.
    Sheard M; Astrachan D; Davis M
    Commun Psychopharmacol; 1977; 1(2):167-73. PubMed ID: 564256
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of the role of serotonin in lithium action using shock-elicited fighting.
    Marini JL; Sheard MH; Kosten T
    Commun Psychopharmacol; 1979; 3(4):225-33. PubMed ID: 93531
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) on shock elicited fighting in rats.
    Walters JK; Sheard MH; Davis M
    Pharmacol Biochem Behav; 1978 Jul; 9(1):87-90. PubMed ID: 279938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced ataxia in opponents elicits "pathological" fighting in undrugged rats exposed to footshock.
    Elliott ML; Sbordone RJ
    Pharmacol Biochem Behav; 1982 Jan; 16(1):63-6. PubMed ID: 7199187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the chronic and acute effects of D-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine.
    Peters DA
    Biochem Pharmacol; 1974 Jan; 23(2):231-7. PubMed ID: 4149793
    [No Abstract]   [Full Text] [Related]  

  • 12. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.
    White FJ; Appel JB
    Science; 1982 Apr; 216(4545):535-7. PubMed ID: 7071600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic effects of LSD and 5-MeODMT on raphe-evoked dorsal root potentials in the cat.
    Larson AA
    Life Sci; 1984 Mar; 34(12):1193-201. PubMed ID: 6708724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

  • 16. Action of hallucinogenic drugs.
    Nature; 1968 Dec; 220(5171):961. PubMed ID: 5701850
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide.
    Gresch PJ; Barrett RJ; Sanders-Bush E; Smith RL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):662-9. PubMed ID: 17077317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some metabolic and behavioural effects of LSD.
    Kabes J; Fink Z; Somlev A; Vrba J; Mádlo Z
    Act Nerv Super (Praha); 1972 Nov; 14(4):294-5. PubMed ID: 5083833
    [No Abstract]   [Full Text] [Related]  

  • 19. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).
    Backstrom JR; Chang MS; Chu H; Niswender CM; Sanders-Bush E
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):77S-81S. PubMed ID: 10432492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of tolerance to the depression of raphe unit activity by lysergic acid diethylamide.
    Trulson ME; Ross CA; Jacobs BL
    Neuropharmacology; 1977 Nov; 16(11):771-4. PubMed ID: 593537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.